1226 Laminoplasty Offers Similar Initial Improvement, but Better Long-Term Improvement Between 12 and 24 Months vs ACDF and PCF: A Quality Outcomes Database Study

INTRODUCTION: Despite its distinct advantages, laminoplasty remains relatively underexplored in comparison to ACDF and PCF regarding long-term patient reported outcome measures (PROMs). METHODS: The Quality Outcome Database was queried for patients who underwent ACDF, PCF or laminoplasty. Primary exposure variable was laminoplasty versus ACDF/PCF. Outcome were difference in improvement in PROMs at 12, and 24 months; operative blood loss; and length of stay. Linear regression models were fitted for PROMs. RESULTS: Of 2977 patients included (mean age 60.9±11.3; 51.1% male), 2270 (76.3%) underwent ACDF, 643 (21.6%) PCF and 64 (2.1%) laminoplasty. At 12-months, PCF patients had greater arm pain improvement than laminoplasty patients (β=1.08, 95%CI=0.21-1.94, p=0.015). ACDF patients had greater improvements in neck pain (β=0.61, 95%CI=0.34-0.88, p<.001), arm pain (β=0.42, 95%CI=0.13-0.72, p=0.005), and NDI (β=6.31, 95%CI=2.03-10.58, p=.004) but worse improvement in EQ5D (β=-0.07, 95%CI=-0.12--0.02, p=0.008) than laminoplasty patients. At 24-months, there was no significant difference in improvements between laminoplasty patients and ACDF/PCF patients (all p>0.05). Between 12 and 24 months, laminoplasty patients had greater improvement in neck pain (0.7±0.6 vs. 0.1±0.2 vs. -0.1±0.1), arm pain (1.1±0.7 vs. -0.0±0.2 vs. -0.1±0.1), and NDI (1.9±3.3 vs. -0.5±1.1, -0.9±0.6) than PCF and ACDF patients. Laminoplasty patients were predicted to have less blood loss (EMM=145.7±17.6, p=.012) and length of stay (IRR=0.81, 95%CI=0.69-0.95, p=.012) than PCF patients. CONCLUSIONS: Laminoplasty patients demonstrated worse neck pain, arm pain, NDI but better EQ5D improvement than ACDF and comparable improvements to PCF patients by 12-months. Importantly, between 12-24 months, laminoplasty patients achieved improvement in all PROMs whereas ACDF and PCF patients plateaued, suggesting that laminoplasty may offer better long-term improvement in PROs when compared to ACDF and PCF patients.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_1226
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1226 Laminoplasty Offers Similar Initial Improvement, but Better Long-Term Improvement Between 12 and 24 Months vs ACDF and PCF: A Quality Outcomes Database Study

Julian Lugo-Pico, Scott L. Zuckerman, Omar Zakieh, Jacquelyn S. Pennings et al.
Neurosurgery
Spine and Intervertebral Disc Pathology
article

1226 Laminoplasty Offers Similar Initial Improvement, but Better Long-Term Improvement Between 12 and 24 Months vs ACDF and PCF: A Quality Outcomes Database Study

Julian Lugo-Pico, Scott L. Zuckerman, Omar Zakieh, Jacquelyn S. Pennings, Raymond Joseph Gardocki, Byron F. Stephens, Amir Mohamad Abtahi, Claudia Davidson, Mason Shing Young, Mitchell Bowers, William Hunter Waddel
article en

Abstract

INTRODUCTION: Despite its distinct advantages, laminoplasty remains relatively underexplored in comparison to ACDF and PCF regarding long-term patient reported outcome measures (PROMs). METHODS: The Quality Outcome Database was queried for patients who underwent ACDF, PCF or laminoplasty. Primary exposure variable was laminoplasty versus ACDF/PCF. Outcome were difference in improvement in PROMs at 12, and 24 months; operative blood loss; and length of stay. Linear regression models were fitted for PROMs. RESULTS: Of 2977 patients included (mean age 60.9±11.3; 51.1% male), 2270 (76.3%) underwent ACDF, 643 (21.6%) PCF and 64 (2.1%) laminoplasty. At 12-months, PCF patients had greater arm pain improvement than laminoplasty patients (β=1.08, 95%CI=0.21-1.94, p=0.015). ACDF patients had greater improvements in neck pain (β=0.61, 95%CI=0.34-0.88, p<.001), arm pain (β=0.42, 95%CI=0.13-0.72, p=0.005), and NDI (β=6.31, 95%CI=2.03-10.58, p=.004) but worse improvement in EQ5D (β=-0.07, 95%CI=-0.12--0.02, p=0.008) than laminoplasty patients. At 24-months, there was no significant difference in improvements between laminoplasty patients and ACDF/PCF patients (all p>0.05). Between 12 and 24 months, laminoplasty patients had greater improvement in neck pain (0.7±0.6 vs. 0.1±0.2 vs. -0.1±0.1), arm pain (1.1±0.7 vs. -0.0±0.2 vs. -0.1±0.1), and NDI (1.9±3.3 vs. -0.5±1.1, -0.9±0.6) than PCF and ACDF patients. Laminoplasty patients were predicted to have less blood loss (EMM=145.7±17.6, p=.012) and length of stay (IRR=0.81, 95%CI=0.69-0.95, p=.012) than PCF patients. CONCLUSIONS: Laminoplasty patients demonstrated worse neck pain, arm pain, NDI but better EQ5D improvement than ACDF and comparable improvements to PCF patients by 12-months. Importantly, between 12-24 months, laminoplasty patients achieved improvement in all PROMs whereas ACDF and PCF patients plateaued, suggesting that laminoplasty may offer better long-term improvement in PROs when compared to ACDF and PCF patients.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 94%
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.